Delivery Order SPE2DB20D3103-SPE2DB26FL5E2
- Not listed
- The Defense Logistics Agency awarded a $1,190.29 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ml units. This is a non-set-aside competitive award with an ultimate completion date of August 27, 2025, and performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5ML units, with a ceiling value of $1,310.70. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Olopatadine HCL 0.1% eye drops in 5mL quantities, valued at $2,587.17. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Olopatadine HCL 0.1% eye drops (5ml) with a ceiling value of $3,491.87. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 26, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,828.70 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5mL quantities. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of October 31, 2025, issued just one day prior on October 30, 2025. The contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5ml units, with a ceiling value of $2,398.95. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and was awarded on September 5, 2025. The contract represents a non-set-aside award under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Olopatadine HCL 0.1% eye drops (5 mL units) with a ceiling value of $1,148.94. This firm fixed-price delivery order is not set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,082.15 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops in 5 mL quantities. This contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of November 4, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,757.44 to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops (5 mL) under a firm fixed-price contract. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a non-competitive delivery order with no set-aside designation. Performance of this order will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Olopatadine HCL 0.1% eye drops (5ml) with a ceiling value of $1,584.58. The award was made on October 30, 2025, with an ultimate completion date of October 31, 2025, under a firm fixed-price contract type with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL5E2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Olopatadine HCL 0.1% Eye Drops in 5ML units, valued at $1,763.56. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, fulfills this order as a child contract under a larger vehicle supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling competitive awards across multiple therapeutic domains and product categories, positioning it as a critical vendor within the Defense Logistics Agency's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/5/25 |